Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexibility of ultra-long-acting basal insulins around spontaneous exercise in type 1 diabetes
DRKS00018065Phase 4Completed
- Sponsor
- Klinische Abteilung für Endokrinologie und Diabetologie, Medzinische Universität Graz Assoz. Prof. PD. Dr. Harald Sourij Auenbruggerplatz 15 8036 Graz Austria
- Start
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin glargine and insulin degludec in diabetes mellitus type 1 (T1D) (4 arms), sponsored by Klinische Abteilung für Endokrinologie und Diabetologie, Medzinische Universität Graz Assoz. Prof. PD. Dr. Harald Sourij Auenbruggerplatz 15 8036 Graz Austria. Started Jan 2020; status: completed.
02
Drugs
insulin glargineinsulin degludec
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on DRKS00018065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00018065.